120
Participants
Start Date
July 30, 2023
Primary Completion Date
November 25, 2024
Study Completion Date
November 25, 2024
Albumin
20% human albumin solution infusion, to raise and maintain serum albumin levels above 3.0 g/dl. Human albumin solution will be given to those enrolled in the study having serum albumin levels ≤ 3 g/dl to maintain the serum albumin levels above 3 g/dl.
Standard of Care
Standard treatment that the patient would receive had they not been included in the trial.
Institute of Liver & Biliary Sciences, New Delhi
Institute of Liver and Biliary Sciences, India
OTHER